Hence, tumor development is initiated in committed B cells, but then leads to dedifferentiation of the Pax5Jak2/+ B‐ALL cells due to the loss of Pax5 function similar to what is observed upon conditional Pax5 deletion in pro‐B cells (Mikkola et al, 2002). Here, PAX5 is linked to acute lymphoblastic leukemia.